The World Orphan Drug Congress Europe
The Annual European focused Congress will be held in Barcelona for 2018, at the Crowne Plaza Hotel. The Congress focuses on bringing together the worlds of scientific innovation and commercialisation of Orphan Drug Development. The Orphan Drug Congress is an important event for biotech companies to get their latest concepts and innovations on display. Focusing on next generation alternative therapies for those with some of the rarest known conditions.
Helen and Juliet will be making the trip to Barcelona for WODC Europe. The event brings together more than 150 elite speakers to educate and inspire over 500 attendees from big pharma, biotech, payers, patient groups, academics and government bodies. Our attendance at the event is part of our continued passion to try and use our work to assist within orphan indications. The congress also features a Rare Disease Advocacy area which is a new area but we feel may bring an interesting new element to the congress.
As ever with Orphan indications we are hopeful that these large, well supported events will encourage further research into orphan disease and hence eventually find a treatment for some patients and their families. The event explores trends in digital health, biosimilars and more with the aim of uncovering the next big scientific breakthrough.